Table 4.
Association of KIR2DS2 and risk of systemic sclerosis stratified by KIR2DL2 status.
| Systemic sclerosis CF (%) | Healthy controls CF (%) | OR (95% CI) | P-value* | |
|---|---|---|---|---|
| KIR2DL2+ | ||||
| KIR2DS2+ | 31 | 66 | 4·23 (0·50–94·57) | 1·0 |
| KIR2DS2- | 1 | 9 | ||
| KIR2DL2- | ||||
| KIR2DS2+ | 28 | 2 | 10·64 (2·22–69·89) | 0·008 |
| KIR2DS2- | 50 | 38 |
*
Yates' corrected χ2 or Fisher's exact test, adjusted for multiple comparisons (15 tests; see Table 2). Additional results of the table: Mantel–Haenszel odds ratio: 7·94 [95% confidence interval (CI): 2·35–26·78]; adjusted P = 0·003. KIR, killer immunoglobulin-like receptor.